Filed: 11/14/2022ACC: 0001104659-22-118475
π What this filing means
5AM VENTURE MANAGEMENT, LLC filed this quarterly 13FβHR report disclosing 21 equity positions with a total reported market value of $522.0K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
21
Positions
$522.0K
Total AUM (reported)
58.92M
Total Shares
Allocation by class
COM$483.8K92.7%
CLASS A COM$34.5K6.6%
COM CL A$3.7K0.7%
Portfolio Concentration
Top 3$285.5K54.7%
4β10$162.1K31.1%
11β25$74.4K14.2%
Top 3 weight
54.7%
Top 10 weight
85.8%
Voting Authority Distribution
Total shares with voting rights: 58.92M
Sole
Full voting authority
58.92M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole21
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings21
Rows:
CINCOR PHARMA INC
SOLEShares4.94M
TypeSH
Market value$162.1K
31.05%
Sole
4.94M
Shared
0.00
None
0.00
ENTRADA THERAPEUTICS INC
SOLEShares4.41M
TypeSH
Market value$69.5K
13.31%
Sole
4.41M
Shared
0.00
None
0.00
RALLYBIO CORP
SOLEShares3.73M
TypeSH
Market value$54.0K
10.34%
Sole
3.73M
Shared
0.00
None
0.00
PEAR THERAPEUTICS INC
SOLEShares16.90M
TypeSH
Market value$34.5K
6.61%
Sole
16.90M
Shared
0.00
None
0.00
AKOUOS INC
SOLEShares4.14M
TypeSH
Market value$28.0K
5.36%
Sole
4.14M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares6.36M
TypeSH
Market value$25.3K
4.85%
Sole
6.36M
Shared
0.00
None
0.00
SCPHARMACEUTICALS INC
SOLEShares3.33M
TypeSH
Market value$21.7K
4.17%
Sole
3.33M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares1.20M
TypeSH
Market value$17.8K
3.42%
Sole
1.20M
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares400K
TypeSH
Market value$17.8K
3.41%
Sole
400K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares862.29K
TypeSH
Market value$16.9K
3.24%
Sole
862.29K
Shared
0.00
None
0.00
IMPEL NEUROPHARMA INC
SOLEShares2.88M
TypeSH
Market value$14.0K
2.69%
Sole
2.88M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares790.44K
TypeSH
Market value$11.8K
2.26%
Sole
790.44K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares484.89K
TypeSH
Market value$9.9K
1.91%
Sole
484.89K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares508.85K
TypeSH
Market value$9.1K
1.75%
Sole
508.85K
Shared
0.00
None
0.00
HOMOLOGY MEDICINES INC
SOLEShares4.54M
TypeSH
Market value$7.3K
1.40%
Sole
4.54M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares390.56K
TypeSH
Market value$6.4K
1.22%
Sole
390.56K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares446.27K
TypeSH
Market value$6.0K
1.16%
Sole
446.27K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares587.60K
TypeSH
Market value$4.5K
0.86%
Sole
587.60K
Shared
0.00
None
0.00
5 01 ACQUISITION CORP
SOLEShares365.13K
TypeSH
Market value$3.7K
0.70%
Sole
365.13K
Shared
0.00
None
0.00
GEMINI THERAPEUTICS INC
SOLEShares524.50K
TypeSH
Market value$860.00
0.16%
Sole
524.50K
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares1.13M
TypeSH
Market value$712.00
0.14%
Sole
1.13M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CINCOR PHARMA INCSOLE | COM | 4.94M | SH | $162.1K 31.05% | 4.94M | 0.00 | 0.00 |
ENTRADA THERAPEUTICS INCSOLE | COM | 4.41M | SH | $69.5K 13.31% | 4.41M | 0.00 | 0.00 |
RALLYBIO CORPSOLE | COM | 3.73M | SH | $54.0K 10.34% | 3.73M | 0.00 | 0.00 |
PEAR THERAPEUTICS INCSOLE | CLASS A COM | 16.90M | SH | $34.5K 6.61% | 16.90M | 0.00 | 0.00 |
AKOUOS INCSOLE | COM | 4.14M | SH | $28.0K 5.36% | 4.14M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM | 6.36M | SH | $25.3K 4.85% | 6.36M | 0.00 | 0.00 |
SCPHARMACEUTICALS INCSOLE | COM | 3.33M | SH | $21.7K 4.17% | 3.33M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 1.20M | SH | $17.8K 3.42% | 1.20M | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 400K | SH | $17.8K 3.41% | 400K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 862.29K | SH | $16.9K 3.24% | 862.29K | 0.00 | 0.00 |
IMPEL NEUROPHARMA INCSOLE | COM | 2.88M | SH | $14.0K 2.69% | 2.88M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 790.44K | SH | $11.8K 2.26% | 790.44K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 484.89K | SH | $9.9K 1.91% | 484.89K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 508.85K | SH | $9.1K 1.75% | 508.85K | 0.00 | 0.00 |
HOMOLOGY MEDICINES INCSOLE | COM | 4.54M | SH | $7.3K 1.40% | 4.54M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 390.56K | SH | $6.4K 1.22% | 390.56K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 446.27K | SH | $6.0K 1.16% | 446.27K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 587.60K | SH | $4.5K 0.86% | 587.60K | 0.00 | 0.00 |
5 01 ACQUISITION CORPSOLE | COM CL A | 365.13K | SH | $3.7K 0.70% | 365.13K | 0.00 | 0.00 |
GEMINI THERAPEUTICS INCSOLE | COM | 524.50K | SH | $860.00 0.16% | 524.50K | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM | 1.13M | SH | $712.00 0.14% | 1.13M | 0.00 | 0.00 |